CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve HIV treatment outcomes for infants in sub-Saharan Africa by adding long-lasting antibodies to standard antiretroviral therapy. It seeks to enhance viral suppression rates and reduce mortality in high-risk infants diagnosed with HIV.
Early ARV treatment in sub-Saharan Africa (SSA) reaches only approximately 50% of infants born with HIV.
Mortality in infants in the first 12 months after diagnosis is still over 10% in early treated infants diagnosed at birth, 25% in infants diagnosed with opportunistic infections.
According to our experience, the probability of virological control 1 year after diagnosis is only 25 to 35%, even after the rollout of dolutegravir (DTG).As a solution for this problem, we propose the addition of fo…
SERVICIO MADRILENO DE SALUD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
FUNDACION PARA LA INVESTIGACION E INNOVACION BIOMEDICA DEL HU INFANTA SOFIA Y DEL HENARES
Spain, MADRID
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
